Cited by 10Heat shock proteins researchAlzheimer's disease research and treatmentsBiochemical and Structural Characterization

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

The bacterial chaperone CsgC inhibits functional amyloid CsgA formation by promoting the intrinsically disordered pre-nuclear state

Open access

Published version of a preprint

Abstract

Escherichia coli assembles a functional amyloid called curli during biofilm formation. The major curlin subunit is the CsgA protein, which adopts a beta-sheet-rich fold upon fibrillization. The chaperone protein CsgC inhibits CsgA amyloid formation. CsgA undergoes a 3-stage aggregation process: an initial lag phase where beta-rich nuclei form, an exponential elongation phase, and a plateau phase. It is currently not known whether CsgC inhibits amyloid formation by inhibiting the formation of a pre-fibril nucleus or whether CsgC inhibits a later stage of amyloid formation by blocking monomer addition. Here, CsgC homologs from Citrobacter youngae, Cedecea davisae, and Hafnia alvei were purified and characterized for their ability to interrogate CsgA amyloid formation. Each of the CsgC homologs prolonged the lag phase of E. coli CsgA amyloid formation, similar to E. coli CsgC. Additionally, we found E. coli CsgC interacted transiently and weakly with a monomeric, pre-nucleus species of CsgA, which delayed amyloid formation. A transient CsgC-CsgA heterodimer was observed using ion mobility-mass spectrometry. When CsgC was added to actively polymerizing CsgA, exponential growth commonly associated with nucleation-dependent amyloid formation was lost. Adding preformed CsgA seeds did not rescue exponential growth, indicating that CsgC also has inhibitory activity during fibril elongation. Indeed, CsgC interacted strongly with CsgA fibers, suggesting that the interaction between CsgC and CsgA fibers can slow new fiber growth. CsgC displays unique inhibitory activity at multiple stages of amyloid formation and acts as an energy-independent chaperone that transiently interacts with prefibrillar CsgA and an amyloid fiber.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jbc.2025.110217

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 50

  1. Chiti, 2017, Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade, Annu. Rev. Biochem., 86, 27, 10.1146/annurev-biochem-061516-045115 · DOI · Paper page
  2. Chiti, 2006, Protein misfolding, functional amyloid, and human disease, Annu. Rev. Biochem., 75, 333, 10.1146/annurev.biochem.75.101304.123901 · DOI
  3. Bucciantini, 2002, Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases, Nat., 6880, 507, 10.1038/416507a · DOI · Paper page
  4. Haass, 2007, Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid β-peptide, Nat. Rev. Mol. Cell Biol., 2, 101, 10.1038/nrm2101 · DOI · Paper page
  5. Balistreri, 2020, Functional amyloids are the rule rather than the exception in cellular Biology, Microorganisms, 8, 1951, 10.3390/microorganisms8121951 · DOI
  6. Chapman, 2002, Role of Escherichia coli curli operons in directing amyloid fiber formation, Science, 295, 851, 10.1126/science.1067484 · DOI
  7. Otzen, 2010, Functional amyloid: turning swords into plowshares, Prion., 4, 256, 10.4161/pri.4.4.13676 · DOI
  8. Deshmukh, 2018, Amyloid by design: intrinsic regulation of microbial amyloid assembly, J. Mol. Biol., 430, 3631, 10.1016/j.jmb.2018.07.007 · DOI
  9. Nenninger, 2011, CsgE is a curli secretion specificity factor that prevents amyloid fibre aggregation, Mol. Microbiol., 81, 486, 10.1111/j.1365-2958.2011.07706.x · DOI
  10. Hammer, 2007, The curli nucleator protein, CsgB, contains an amyloidogenic domain that directs CsgA polymerization, Proc. Natl. Acad. Sci. U. S. A., 104, 12494, 10.1073/pnas.0703310104 · DOI
  11. Nenninger, 2009, Localized and efficient curli nucleation requires the chaperone-like amyloid assembly protein CsgF, Proc. Natl. Acad. Sci. U. S. A., 106, 900, 10.1073/pnas.0812143106 · DOI
  12. Evans, 2015, The bacterial curli system possesses a potent and selective inhibitor of amyloid formation, Mol. Cell., 57, 445, 10.1016/j.molcel.2014.12.025 · DOI
  13. Taylor, 2011, Atomic resolution insights into curli fiber biogenesis, Structure, 19, 1307, 10.1016/j.str.2011.05.015 · DOI
  14. Taylor, 2016, Electrostatically-guided inhibition of Curli amyloid nucleation by the CsgC-like family of chaperones, Sci. Rep., 6, 10.1038/srep24656 · DOI
  15. Rochet, 2000, Amyloid fibrillogenesis: themes and variations, Curr. Opin. Struct. Biol., 10, 60, 10.1016/S0959-440X(99)00049-4 · DOI
  16. Evans, 2015, The bacterial curli System possesses a potent and selective inhibitor of amyloid formation, Mol. Cell., 57, 445, 10.1016/j.molcel.2014.12.025 · DOI
  17. Nagaraj, 2022, Chaperones mainly suppress primary nucleation during formation of functional amyloid required for bacterial biofilm formation, Chem. Sci., 13, 536, 10.1039/D1SC05790A · DOI
  18. Sleutel, 2017, Nucleation and growth of a bacterial functional amyloid at single-fiber resolution, Nat. Chem. Biol., 13, 902, 10.1038/nchembio.2413 · DOI
  19. Zhou, 2012, Promiscuous cross-seeding between bacterial amyloids promotes interspecies biofilms, J. Biol. Chem., 287, 35092, 10.1074/jbc.M112.383737 · DOI
  20. Salgado, 2011, Extending the usability of the phasing power of diselenide bonds: SeCys SAD phasing of CsgC using a non-auxotrophic strain, Acta Crystallogr. D Biol. Crystallogr., 67, 8, 10.1107/S0907444910042022 · DOI
  21. Balistreri, 2020, Tuning functional amyloid formation through disulfide engineering, Front. Microbiol., 11, 944, 10.3389/fmicb.2020.00944 · DOI
  22. Brännström, 2011, Aβ peptide fibrillar architectures controlled by conformational constraints of the monomer, PLoS One, 6, 10.1371/journal.pone.0025157 · DOI
  23. Arosio, 2015, On the lag phase in amyloid fibril formation, Phys. Chem. Chem. Phys., 17, 7606, 10.1039/C4CP05563B · DOI
  24. Dueholm, 2012, Curli functional amyloid systems are phylogenetically widespread and display large diversity in operon and protein structure, PLoS One, 7, e51274, 10.1371/journal.pone.0051274 · DOI
  25. Meisl, 2016, Molecular mechanisms of protein aggregation from global fitting of kinetic models, Nat. Protoc., 2, 252, 10.1038/nprot.2016.010 · DOI
  26. Collins, 2004, Mechanism of prion propagation: amyloid growth occurs by monomer addition, PLoS Biol., 2, 10.1371/journal.pbio.0020321 · DOI
  27. Jahn, 2008, Folding versus aggregation: polypeptide conformations on competing pathways, Arch. Biochem. Biophys., 469, 100, 10.1016/j.abb.2007.05.015 · DOI
  28. Dueholm, 2011, Fibrillation of the major curli subunit CsgA under a wide range of conditions implies a robust design of aggregation, Biochemistry, 50, 8281, 10.1021/bi200967c · DOI
  29. Wang, 2007, In vitro polymerization of a functional Escherichia coli amyloid protein, J. Biol. Chem., 282, 3713, 10.1074/jbc.M609228200 · DOI
  30. Homola, 2008, Surface plasmon resonance sensors for detection of chemical and biological species, Chem. Rev., 108, 462, 10.1021/cr068107d · DOI
  31. May, 2015, Ion mobility-mass spectrometry: time-dispersive instrumentation, Anal. Chem., 87, 1422, 10.1021/ac504720m · DOI
  32. Santambrogio, 2019, Conformational characterization and classification of intrinsically disordered proteins by native mass spectrometry and charge-state distribution analysis, Proteomics, 19, 10.1002/pmic.201800060 · DOI · Paper page
  33. Baumketner, 2006, Amyloid β-protein monomer structure: a computational and experimental study, Protein Sci., 15, 420, 10.1110/ps.051762406 · DOI
  34. Hyung, 2013, Insights into antiamyloidogenic properties of the green tea extract (-)-epigallocatechin-3-gallate toward metal-associated amyloid-β species, Proc. Natl. Acad. Sci. U. S. A., 110, 3743, 10.1073/pnas.1220326110 · DOI
  35. Soper, 2013, Amyloid-beta-neuropeptide interactions assessed by ion mobility-mass spectrometry, Phys. Chem. Chem. Phys., 15, 8952, 10.1039/c3cp50721a · DOI
  36. Sievers, 2011, Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation, Nat., 7354, 96, 10.1038/nature10154 · DOI
  37. Chan, 2008, Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrils, Biochemistry, 47, 11041, 10.1021/bi8005797 · DOI
  38. Giorgetti, 2018, Targeting amyloid aggregation: an overview of strategies and mechanisms, Int. J. Mol. Sci., 19, 2677, 10.3390/ijms19092677 · DOI
  39. Arosio, 2016, Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation, Nat. Commun., 1, 1
  40. Jahn, 2008, Folding versus aggregation: polypeptide conformations on competing pathways, Arch. Biochem. Biophys., 469, 100, 10.1016/j.abb.2007.05.015 · DOI
  41. Van Gerven, 2015, Bacterial amyloid formation: structural insights into curli biogensis, Trends Microbiol., 23, 693, 10.1016/j.tim.2015.07.010 · DOI
  42. Andreasen, 2019, Physical determinants of amyloid assembly in biofilm formation, mBio, 10, 10.1128/mBio.02279-18 · DOI
  43. Frieden, 2007, Protein aggregation processes: in search of the mechanism, Protein Sci., 16, 2334, 10.1110/ps.073164107 · DOI
  44. Jain, 2011, Prion protein aggregation, Curr Sci., 10, 1311
  45. Olsen, 2024, CsgA gatekeeper residues control nucleation but not stability of functional amyloid, Protein Sci., 33, e5178, 10.1002/pro.5178 · DOI
  46. Meisl, 2022, Uncovering the universality of self-replication in protein aggregation and its link to disease, Sci. Adv., 8, 10.1126/sciadv.abn6831 · DOI
  47. Baker, 2001, Electrostatics of nanosystems: Application to microtubules and the ribosome, Proc. Natl. Acad. Sci., 98, 10037, 10.1073/pnas.181342398 · DOI
  48. Katoh, 2005, MAFFT version 5: improvement in accuracy of multiple sequence alignment, Nucleic Acids Res, 33, 511, 10.1093/nar/gki198 · DOI
  49. Livingstone, 1993, Protein sequence alignments: a strategy for the hierarchical analysis of residue conservation, Bioinformatics, 9, 745, 10.1093/bioinformatics/9.6.745 · DOI
  50. Casadaban, 1980, Analysis of gene control signals by DNA fusion and cloning in Escherichia coli, J. Mol. Biol., 138, 179, 10.1016/0022-2836(80)90283-1 · DOI

Metadata

Authors
Balistreri, A., Kolli, D., Jayaweera, S. W., Lundahl, D., Han, Y., Kalcec, L., Goetzler, E., Alessio, R., Ruotolo, B., Olofsson, A., & Chapman, M. R.
Affiliations
  • University of Michigan (US)
  • Umeå University (SE)
Corresponding author
Chapman, Matthew R.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2025-06
Volume
301
Issue
6
Pages
110217
ISSN
0021-9258 (ISSN-L)
OpenAlex
W4410200313
Cited by
10
References
2
Citations by year
2026: 9 · 2025: 1
FWCI
3.01
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion)
  • Diva portal (Dalarna University Library) (submittedVersion, other-oa)
Funders
  • National Institutes of Health (R01 GM095832, R21 AI137535, R01 GM118651, T32 AI007528)
  • Foundation for the National Institutes of Health (R01 GM095832, T32 AI007528, R21 AI137535, R01 GM118651)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Structural Characterization
Keywords
CsgA, curli, functional amyloids, amyloid formation inhibition, molecular chaperones, nucleation, fibril elongation, Escherichia coli biofilm, heterodimer, Citrobacter youngae, Cedecea davisae, Hafnia alvei

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review